Parathyroid cancer medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 25: Line 25:
* [[Calcimimetic agents]] that directly block secretion of the parathyroid hormone from the glands  
* [[Calcimimetic agents]] that directly block secretion of the parathyroid hormone from the glands  
:* [[Gallium nitrate]] is used to reduce the [[calcium levels]].
:* [[Gallium nitrate]] is used to reduce the [[calcium levels]].
:* [[Calcitonin]] is used to control the calcium levels.
:* [[Calcitonin]] is used to control the calcium levels.<ref> Parathyroid cancer. Cancer.gov (2015). http://www.cancer.gov/types/parathyroid/hp  Accessed on December 29, 2015</ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 18:50, 29 December 2015

Parathyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Parathyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Parathyroid cancer medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Parathyroid cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Parathyroid cancer medical therapy

CDC on Parathyroid cancer medical therapy

Parathyroid cancer medical therapy in the news

Blogs on Parathyroid cancer medical therapy

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Parathyroid cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

The predominant therapy for parathyroid cancer is surgical resection. Adjunctive supportive therapy, chemotherapy, and radiation may be required. Supportive therapy for parathyroid cancer includes IV fluids, diuretics, and calcimimetic agents.

Medical Therapy

  • There are different types of treatment for patients with parathyroid cancer.
  • Treatment includes control of hypercalcemia (too much calcium in the blood) in patients who have an overactive parathyroid gland.

Standard Therapy

  • Four types of standard treatment are used:

Radiation therapy

Chemotherapy

  • Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.

Supportive care

  • Supportive care is given to lessen the problems caused by the disease or its treatment. Supportive care for hypercalcemia caused by parathyroid cancer may include the following:

References

  1. Parathyroid cancer. Cancer.gov (2015). http://www.cancer.gov/types/parathyroid/hp Accessed on December 29, 2015


Template:WikiDoc Sources